CCMU
ZYME icon

Cheyne Capital Management (UK)’s Zymeworks ZYME Stock Holding History

Cheyne Capital Management (UK)’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,750
Closed -$640K – 103
2020
Q3 		$640K Buy
+13,750
New +$472K 0.32% 50

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Cheyne Capital Management (UK)'s ZYME Position: Q4 2020 in Review

Cheyne Capital Management (UK) sold out of Zymeworks (ZYME) in Q4 2020, closing a stake of 13,750 shares — an estimated $640K sold.

Cheyne Capital Management (UK) first reported a position in ZYME in Q3 2020 and held it in 1 quarter. The position peaked at $640K in Q3 2020. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.

  • Cheyne Capital Management (UK) reported no remaining Zymeworks position as of Q4 2020 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 13,750 Zymeworks shares in Q4 2020, an estimated $640K.
  • Cheyne Capital Management (UK) first reported a position in Zymeworks in Q3 2020 and held it in 1 quarter.
  • Cheyne Capital Management (UK)'s Zymeworks position peaked at $640K in Q3 2020.
  • 138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2020, filed 10 Feb 2021.